INSERM, UMRS 1166, team "Integrative Biology of Atherosclerosis", Sorbonne Universités, Hôpital Pitié-Salpêtrière, Paris, France.
Institute of Cardiometabolism and Nutrition (ICAN), Hôpital Pitié-Salpêtrière, Paris, France.
BMC Biol. 2019 Nov 27;17(1):94. doi: 10.1186/s12915-019-0715-8.
Management of blood cholesterol is a major focus of efforts to prevent cardiovascular diseases. The objective of this study was to investigate how the gut microbiota affects host cholesterol homeostasis at the organism scale.
We depleted the intestinal microbiota of hypercholesterolemic female Apoe mice using broad-spectrum antibiotics. Measurement of plasma cholesterol levels as well as cholesterol synthesis and fluxes by complementary approaches showed that the intestinal microbiota strongly regulates plasma cholesterol level, hepatic cholesterol synthesis, and enterohepatic circulation. Moreover, transplant of the microbiota from humans harboring elevated plasma cholesterol levels to recipient mice induced a phenotype of high plasma cholesterol levels in association with a low hepatic cholesterol synthesis and high intestinal absorption pattern. Recipient mice phenotypes correlated with several specific bacterial phylotypes affiliated to Betaproteobacteria, Alistipes, Bacteroides, and Barnesiella taxa.
These results indicate that the intestinal microbiota determines the circulating cholesterol level and may thus represent a novel therapeutic target in the management of dyslipidemia and cardiovascular diseases.
管理血液胆固醇是预防心血管疾病努力的主要焦点。本研究的目的是研究肠道微生物群如何在机体水平上影响宿主胆固醇稳态。
我们使用广谱抗生素耗尽了高脂血症雌性 Apoe 小鼠的肠道微生物群。通过补充方法测量血浆胆固醇水平以及胆固醇合成和通量表明,肠道微生物群强烈调节血浆胆固醇水平、肝胆固醇合成和肠肝循环。此外,将来自血浆胆固醇水平升高的人类的微生物群移植到受体小鼠中,导致与低肝胆固醇合成和高肠道吸收模式相关的高血浆胆固醇水平表型。受体小鼠的表型与几种特定的细菌菌群有关,这些菌群与 Betaproteobacteria、Alistipes、Bacteroides 和 Barnesiella 分类群有关。
这些结果表明,肠道微生物群决定了循环胆固醇水平,因此可能成为治疗血脂异常和心血管疾病的新靶点。